Polypharmacological strategies for infectious bacteria

Area of Science:

• Microbiology
• Pharmacology
• Medicinal Chemistry

Background:

• Antibiotic resistance is a growing global health threat, necessitating novel therapeutic strategies.
• Monotherapy for complex bacterial infections often faces limitations and resistance development.
• Biofilm-associated infections present unique challenges due to their inherent resistance mechanisms.

Purpose of the Study:

• To review polypharmacological approaches for treating bacterial infections, with a focus on biofilm-related diseases.
• To highlight the potential of antibiotic hybrids as multitargeting agents against resistant bacteria.
• To underscore the need for further research into innovative treatments for infectious diseases.

Main Methods:

• Literature review of polypharmacological strategies and antibiotic hybrids.
• Analysis of multitargeting agents' mechanisms against bacterial pathogens.
• Exploration of applications in combating antibiotic resistance and biofilm infections.

Main Results:

• Polypharmacological approaches, particularly antibiotic hybrids, demonstrate potential for enhanced therapeutic effects.
• Multitargeting agents can overcome monotherapy drawbacks and reduce resistance development.
• Antibiotic hybrids offer synergistic interactions, broader spectrum of action, and improved stability.
• A significant research gap exists in treating biofilm-associated bacterial infections.

Conclusions:

• Antibiotic hybrids represent a rational and sustainable strategy to combat antibiotic resistance.
• Further research into polypharmacological approaches is crucial for developing effective treatments for bacterial infections, including biofilm-related ones.
• Innovative strategies are needed to address the escalating challenge of antimicrobial resistance.